vimarsana.com
Home
Live Updates
Submit Comments - Breaking News
Pages:
12
13
14
15
16
17
18
Page 11 - Submit Comments News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products
Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Prescription Drug User Fee Act Products
Guidance issuing office
Drug administration
Submit comments
Drug evaluation
Biologics evaluation
Meeting formats
Demonstrating Substantial Evidence of Effectiveness Based on One Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence
Demonstrating Substantial Evidence of Effectiveness Based on One Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence
Guidance issuing office
Drug administration
Oncology center
Submit comments
Drug evaluation
Biologics evaluation
Substantial evidence
Effectiveness based
One adequate
Well controlled clinical investigation
Confirmatory evidence
Human drug
Clinical evidence
Regulatory Considerations for Prescription Drug Use-Related Software
Regulatory Considerations for Prescription Drug Use-Related Software
Drug administration
Guidance issuing office
Radiological health
Oncology center
Submit comments
Drug evaluation
Biologics evaluation
Federal register
Drug use related software
Public docket
Labeling for Biosimilar and Interchangeable Biosimilar Products
Labeling for Biosimilar and Interchangeable Biosimilar Products
Guidance issuing office
Drug administration
Public health service act
Submit comments
Drug evaluation
Biologics evaluation
Prescribing information
Approved patient labeling
Interchangeable biosimilar products
Patient information
Medication guide
Medical Devices with Indications Associated with Weight Loss - Non-Clinical Recommendations
Draft guidance provides recommendations for non-clinical testing to support premarket submissions for devices with indications associated with weight loss.
Radiological health
Drug administration
Guidance issuing office
Submit comments
Premarket approval
Investigational device exemption
Premarket notifications
vimarsana © 2020. All Rights Reserved.